‘Phar­ma burnout’: In­dus­try rep­u­ta­tion slumps in first half of 2022, study finds

The bio­phar­ma in­dus­try rep­u­ta­tion is slid­ing again — and alarm­ing­ly fast. The phar­ma­ceu­ti­cals, biotech­nol­o­gy and life sci­ences cat­e­go­ry fell al­most 3 points (2.9) be­tween the first …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER